Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anny Shai

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Neuro-Oncology|March 14, 2022
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implicationsEsraa Mohamed, Anupam Kumar, Yalan Zhang, et al.
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 8, 2024
Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse GliomaSol Beccari, Esraa Mohamed, Viva Voong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
NPJ Digital Medicine|June 25, 2026
Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learningJacob Ellison, Nate Tran, Tracy L Luks, et al.
Neuro-Oncology|June 30, 2026
MAPK-driven glioma progression and reprogramming of the tumor-associated immune responseElaheh Hashemi, Ravishkumar Lakshmi Akshaya, Lin Wang, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Scientific Reports|March 17, 2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Neuro-Oncology|March 14, 2022
PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implicationsEsraa Mohamed, Anupam Kumar, Yalan Zhang, et al.
Neuro-Oncology|October 15, 2021
Improving the noninvasive classification of glioma genetic subtype with deep learning and diffusion-weighted imagingJulia Cluceru, Yannet Interian, Joanna J Phillips, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 8, 2024
Quantitative Assessment of Preanalytic Variables on Clinical Evaluation of PI3/AKT/mTOR Signaling Activity in Diffuse GliomaSol Beccari, Esraa Mohamed, Viva Voong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2022
CXCL14 Promotes a Robust Brain Tumor-Associated Immune Response in GliomaAnupam Kumar, Esraa Mohamed, Schuyler Tong, et al.
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
NPJ Digital Medicine|June 25, 2026
Spatially identifying regions of tumor recurrence in patients with suspected recurrent glioma using physiologic MRI and machine learningJacob Ellison, Nate Tran, Tracy L Luks, et al.
Neuro-Oncology|June 30, 2026
MAPK-driven glioma progression and reprogramming of the tumor-associated immune responseElaheh Hashemi, Ravishkumar Lakshmi Akshaya, Lin Wang, et al.
Neuro-Oncology|April 6, 2021
Temozolomide-induced hypermutation is associated with distant recurrence and reduced survival after high-grade transformation of low-grade IDH-mutant gliomasYao Yu, Javier Villanueva-Meyer, Matthew R Grimmer, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Scientific Reports|March 17, 2024
Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in gliomaTakahide Nejo, Lin Wang, Kevin K Leung, et al.
Pageof 3